title: Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma.
authors.affiliation: Innere Klinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, Federal Republic of Germany.
authors.forename: R
authors.initials: R
authors.lastname: Becher
authors.forename: O
authors.initials: O
authors.lastname: Kloke
authors.forename: K
authors.initials: K
authors.lastname: Höffken
authors.forename: M E
authors.initials: ME
authors.lastname: Scheulen
authors.forename: U B
authors.initials: UB
authors.lastname: Wandl
authors.forename: H
authors.initials: H
authors.lastname: Bojar
authors.forename: C G
authors.initials: CG
authors.lastname: Schmidt
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D008545:Melanoma / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone